Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Ecteinascidin 743

EU orphan designation number: EU/3/01/039   
Active ingredient: Ecteinascidin 743
Indication: Treatment of soft tissue sarcoma
Sponsor: Pharma Mar S.A.
Avenida de los Reyes 1, Poligono Industrial La Mina, E-28770 Colmenar Viejo, Madrid, Espańa
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name Yondelis on 17/09/2007 with the number EU/1/07/417

   Public summary of scientific opinion     EPAR

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/05/2006 Centralised Orphan - Designation EMEA/OD/001/01 (2001)1500 of 30/05/2001
01/09/2006 Other procedure